Cargando…

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo (1)H-Magnetic Resonance Spectroscopy and Machine Learning

SIMPLE SUMMARY: Approximately 75–80% of according to the classification of world health organization (WHO) grade II and III gliomas are characterized by a mutation of the isocitrate dehydrogenase (IDH) enzymes, which are very important in glioma cell metabolism. Patients with IDH mutated glioma have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bumes, Elisabeth, Wirtz, Fro-Philip, Fellner, Claudia, Grosse, Jirka, Hellwig, Dirk, Oefner, Peter J., Häckl, Martina, Linker, Ralf, Proescholdt, Martin, Schmidt, Nils Ole, Riemenschneider, Markus J., Samol, Claudia, Rosengarth, Katharina, Wendl, Christina, Hau, Peter, Gronwald, Wolfram, Hutterer, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698334/ https://www.ncbi.nlm.nih.gov/pubmed/33212941 http://dx.doi.org/10.3390/cancers12113406

Ejemplares similares

Validation Study for Non-Invasive Prediction of IDH Mutation Status in Patients with Glioma Using In Vivo (1)H-Magnetic Resonance Spectroscopy and Machine Learning
por: Bumes, Elisabeth, et al.
Publicado: (2022)

Does the distance to the cancer center affect psycho-oncological care and emergency visits of patients with IDH wild-type gliomas? A retrospective study
por: Fischl, Anna, et al.
Publicado: (2023)

Robust Metabolite Quantification from J-Compensated 2D (1)H-(13)C-HSQC Experiments
por: Weitzel, Alexander, et al.
Publicado: (2020)

Single-institution cross-sectional study to evaluate need for information and need for referral to psychooncology care in association with depression in brain tumor patients and their family caregivers
por: Reinert, Christiane, et al.
Publicado: (2020)

Breakouts—A Radiological Sign of Poor Prognosis in Patients With Brain Metastases
por: Blazquez, Raquel, et al.
Publicado: (2022)

fMRI Retinotopic Mapping in Patients with Brain Tumors and Space-Occupying Brain Lesions in the Area of the Occipital Lobe
por: Hense, Katharina, et al.
Publicado: (2021)

Isotope Ratio Outlier Analysis (IROA) for HPLC–TOFMS-Based Metabolomics of Human Urine
por: Fadil, Fadi, et al.
Publicado: (2022)

A comprehensive DNA panel next generation sequencing approach supporting diagnostics and therapy prediction in neurooncology
por: Lorenz, Julia, et al.
Publicado: (2020)

Combined Modulation of Tumor Metabolism by Metformin and Diclofenac in Glioma
por: Gerthofer, Valeria, et al.
Publicado: (2018)

Assessment of Physiological Rat Kidney Ageing—Implications for the Evaluation of Allograft Quality Prior to Renal Transplantation
por: Baumgartner, Andreas, et al.
Publicado: (2022)

Lactonization of the Oncometabolite D-2-Hydroxyglutarate Produces a Novel Endogenous Metabolite
por: Berger, Raffaela S., et al.
Publicado: (2021)

Predicting IDH genotype in gliomas using FET PET radiomics
por: Lohmann, Philipp, et al.
Publicado: (2018)

Molecular dissection of the valproic acid effects on glioma cells
por: Hoja, Sabine, et al.
Publicado: (2016)

Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center
por: Haj, Amer, et al.
Publicado: (2017)

Isolated metastasis of an EGFR-L858R-mutated NSCLC of the meninges: the potential impact of CXCL12/CXCR4 axis in EGFR(mut) NSCLC in diagnosis, follow-up and treatment
por: Lüke, Florian, et al.
Publicado: (2018)

(18)F-FET PET Uptake Characteristics of Long-Term IDH-Wildtype Diffuse Glioma Survivors
por: Mittlmeier, Lena M., et al.
Publicado: (2021)

Heterogeneity of Amino Acid Profiles of Proneural and Mesenchymal Brain-Tumor Initiating Cells
por: Seliger, Corinna, et al.
Publicado: (2023)

Clinical Benefits of Combining Different Visualization Modalities in Neurosurgery
por: Schebesch, Karl-Michael, et al.
Publicado: (2019)

Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive Phenotype
por: Braun, Frank K., et al.
Publicado: (2023)

ATF4 contributes to autophagy and survival in sunitinib treated brain tumor initiating cells (BTICs)
por: Moeckel, Sylvia, et al.
Publicado: (2019)

An Intra-Individual Comparison of MRI, [(18)F]-FET and [(18)F]-FLT PET in Patients with High-Grade Gliomas
por: Nowosielski, Martha, et al.
Publicado: (2014)

Validation Study: Response-Predictive Gene Expression Profiling of Glioma Progenitor Cells In Vitro
por: Moeckel, Sylvia, et al.
Publicado: (2016)

Use of statins or NSAIDs and survival of patients with high-grade glioma
por: Seliger, Corinna, et al.
Publicado: (2018)

An R-Package for the Deconvolution and Integration of 1D NMR Data: MetaboDecon1D
por: Häckl, Martina, et al.
Publicado: (2021)

FDG-PET Imaging for Hodgkin and Diffuse Large B-Cell Lymphoma—An Updated Overview
por: Voltin, Conrad-Amadeus, et al.
Publicado: (2020)

Differentiated Thyroid Cancer—Treatment: State of the Art
por: Schmidbauer, Benedikt, et al.
Publicado: (2017)

L-type amino acid transporter (LAT) 1 expression in (18)F-FET-negative gliomas
por: Vettermann, Franziska J., et al.
Publicado: (2021)

Efficacy of D,L-methadone in the treatment of glioblastoma in vitro
por: Brawanski, Konstantin, et al.
Publicado: (2018)

Prediction of Glioma Grade and IDH Status Using (18)F-FET PET/CT Dynamic and Multiparametric Texture Analysis
por: Hajri, Rami, et al.
Publicado: (2023)

TGF-Δ isoforms in cancer: Immunohistochemical expression and Smad-pathway-activity-analysis in thirteen major tumor types with a critical appraisal of antibody specificity and immunohistochemistry assay validity
por: Riemenschneider, Markus J., et al.
Publicado: (2015)

Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation
por: Leidgens, Verena, et al.
Publicado: (2016)

Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [(18)F]FET PET radiomics
por: Li, Zhicong, et al.
Publicado: (2021)

Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis
por: Neumann, Bernhard, et al.
Publicado: (2023)

Combination of pre-treatment dynamic [(18)F]FET PET radiomics and conventional clinical parameters for the survival stratification in patients with IDH-wildtype glioblastoma
por: Li, Zhicong, et al.
Publicado: (2022)

Prognostic value of pre-irradiation FET PET in patients with not completely resectable IDH-wildtype glioma and minimal or absent contrast enhancement
por: Rosen, Jurij, et al.
Publicado: (2021)

The Value of FET PET/CT in Recurrent Glioma with a Different IDH Mutation Status: The Relationship between Imaging and Molecular Biomarkers
por: Skoblar Vidmar, Marija, et al.
Publicado: (2022)

Systematic Evaluation of Non-Uniform Sampling Parameters in the Targeted Analysis of Urine Metabolites by (1)H,(1)H 2D NMR Spectroscopy
por: Schlippenbach, Trixi von, et al.
Publicado: (2018)

A Preliminary Study on Machine Learning-Based Evaluation of Static and Dynamic FET-PET for the Detection of Pseudoprogression in Patients with IDH-Wildtype Glioblastoma
por: Kebir, Sied, et al.
Publicado: (2020)

Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal Origin
por: Seliger, Corinna, et al.
Publicado: (2022)

Preoperative Assessment of Language Dominance through Combined Resting-State and Task-Based Functional Magnetic Resonance Imaging
por: Ott, Christian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2lgknmqpv4sjf8d2dmhcd1kitp